Author/Authors :
Lim، نويسنده , , Stephen W. and Falk، نويسنده , , Rena E. and Look، نويسنده , , Regan M. and Fuerst، نويسنده , , Marie M. and Lawrence، نويسنده , , Grace N. and Kusuanco، نويسنده , , Donato A. and Giles، نويسنده , , Francis J.، نويسنده ,
Abstract :
We report a patient with a history of leukopenia who developed acute myeloid leukemia (AML) FAB M2 and was successfully treated with induction and consolidation chemotherapy. She relapsed 7 months after initial diagnosis. Peripheral blood cells at relapse showed a t(12;15)(p13;q13), which has not been previously described in de novo or relapsed AML.
